PARMAR KUSH

CIK 000166428118 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001664281

Recent Transactions

50 trades

Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-08-10$7.00/sh−92,444→ 2,691,337 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-08-07$6.85/sh−52,317→ 2,783,781 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-08-06$7.00/sh−10,494→ 2,836,098 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-07-31$6.85/sh−1,718→ 2,846,592 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-07-30$6.93/sh−114,756→ 2,848,310 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2026-06-10+19,000→ 19,000 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-11-14$8.80/sh−200,000→ 2,963,066 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-07-09$7.50/sh−6,935→ 1,093,313 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-07-09$7.50/sh−20,065→ 3,163,066 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-07-01$7.12/sh−6,422→ 1,100,248 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-07-01$7.12/sh−18,578→ 3,183,131 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-06-30$6.81/sh−6,422→ 1,106,670 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-06-30$6.81/sh−18,578→ 3,201,709 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-06-27$6.91/sh−55,735→ 3,220,287 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-06-27$6.91/sh−19,265→ 1,113,092 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2025-06-11+19,000→ 19,000 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-06-13+16,000→ 16,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2024-05-15+16,500→ 16,500 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2024-01-02$1.77/sh+27,118→ 27,118 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-06-08+16,000→ 16,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2023-05-17+15,490→ 15,490 total
Sale
Rallybio Corp$RLYB
Common Stock
2023-03-07$8.20/sh−100,000→ 2,378,969 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2023-01-03+10,344→ 10,344 total
Disposition to Issuer
Akouos, Inc.
Stock Option (right to buy)
2022-12-01−16,000→ 0 total
Disposition from Tender
Akouos, Inc.
Common Stock
2022-11-30−982,453→ 0 total
Disposition from Tender
Akouos, Inc.
Common Stock
2022-11-30−3,153,333→ 0 total
Award
Akouos, Inc.
Stock Option (right to buy)
2022-06-23+16,000→ 16,000 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2022-06-15+18,000→ 18,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2022-06-14+16,911→ 16,911 total
Sale
Rallybio Corp$RLYB
Common Stock
2022-06-03$12.50/sh−99,671→ 2,478,969 total
Sale
Rallybio Corp$RLYB
Common Stock
2022-06-03$12.50/sh−50,329→ 1,251,755 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-06-02+11,918→ 11,918 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2022-05-24+13,440→ 13,440 total
Sale
Rallybio Corp$RLYB
Common Stock
2022-05-23$13.00/sh−33,553→ 1,302,084 total
Sale
Rallybio Corp$RLYB
Common Stock
2022-05-23$13.00/sh−66,447→ 2,578,640 total
Sale
Rallybio Corp$RLYB
Common Stock
2022-02-08$13.05/sh−70,461→ 1,335,637 total
Sale
Rallybio Corp$RLYB
Common Stock
2022-02-08$13.05/sh−139,539→ 2,645,087 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2022-01-03+5,772→ 5,772 total
Sale
Vor Biopharma Inc.$VOR
Common Stock
2021-11-16$15.30/sh−91,836→ 1,766,634 total
Sale
Vor Biopharma Inc.$VOR
Common Stock
2021-11-16$15.30/sh−238,870→ 4,595,089 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Series B Preferred Stock
2021-11-02−318,140→ 0 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Series A Preferred Stock
2021-11-02−564,217→ 0 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Series B Preferred Stock
2021-11-02−254,512→ 0 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Series A Preferred Stock
2021-11-02−2,371,739→ 0 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Series Seed Preferred Stock
2021-11-02−318,616→ 0 total
Purchase
Entrada Therapeutics, Inc.$TRDA
Common Stock
2021-11-02$20.00/sh+250,000→ 1,132,357 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2021-11-02+318,140→ 882,357 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2021-11-02+254,512→ 3,276,022 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2021-11-02+564,217→ 564,217 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2021-11-02+2,371,739→ 3,021,510 total

Companies

Recent Filings

Address

4 EMBARCADERO CENTER, SUITE 3110

SAN FRANCISCO, CA, 94111

View on SEC.gov